{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:54:20Z","timestamp":1784415260329,"version":"3.55.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970461"],"award-info":[{"award-number":["31970461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J01359"],"award-info":[{"award-number":["2024J01359"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Qi-Shan scholar grant of Fuzhou University","award":["GXRC-20070"],"award-info":[{"award-number":["GXRC-20070"]}]},{"name":"Hangzhou Bipolar Biotechnology Co., Ltd.","award":["2023082905"],"award-info":[{"award-number":["2023082905"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06392-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T10:04:18Z","timestamp":1743761058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gene therapy shines light on congenital stationary night blindness for future cures"],"prefix":"10.1186","volume":"23","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5259-7214","authenticated-orcid":false,"given":"Wenfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"6392_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nn0901-877","volume":"4","author":"RH Masland","year":"2001","unstructured":"Masland RH. The fundamental plan of the retina. Nat Neurosci. 2001;4:877\u201386.","journal-title":"Nat Neurosci"},{"key":"6392_CR2","doi-asserted-by":"publisher","first-page":"R706","DOI":"10.1016\/j.cub.2016.03.065","volume":"26","author":"T Baden","year":"2016","unstructured":"Baden T, Euler T. Retinal physiology: Non-Bipolar-Cell excitatory drive in the inner retina. Curr Biol. 2016;26:R706\u20138.","journal-title":"Curr Biol"},{"key":"6392_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1586\/17469899.2.3.467","volume":"2","author":"C Zeitz","year":"2007","unstructured":"Zeitz C. Molecular genetics and protein function involved in nocturnal vision. Expert Rev Ophthalmo. 2007;2:467\u201385.","journal-title":"Expert Rev Ophthalmo"},{"key":"6392_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390:849\u201360.","journal-title":"Lancet"},{"key":"6392_CR5","doi-asserted-by":"publisher","first-page":"14965","DOI":"10.3390\/ijms232314965","volume":"23","author":"AH Kim","year":"2022","unstructured":"Kim AH, Liu P-K, Chang Y-H, Kang EY, Wang H-H, Chen N, Tseng Y-J, Seo GH, Lee H, Liu L, et al. Congenital stationary night blindness: clinical and genetic features. Int J Mol Sci. 2022;23:14965.","journal-title":"Int J Mol Sci"},{"key":"6392_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.oret.2024.03.017","volume":"8","author":"M Katta","year":"2024","unstructured":"Katta M, de Guimaraes TAC, Fujinami-Yokokawa Y, Fujinami K, Georgiou M, Mahroo OA, Webster AR, Michaelides M. Congenital stationary night blindness: structure, function and Genotype-Phenotype correlations in a cohort of 122 patients. Ophthalmol Retina. 2024;8:932\u201341.","journal-title":"Ophthalmol Retina"},{"key":"6392_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-0043-123072","volume":"235","author":"C Zeitz","year":"2018","unstructured":"Zeitz C, Friedburg C, Preising MN, Lorenz B. Overview of congenital stationary night blindness with predominantly normal fundus appearance. Klin Monbl Augenheilkd. 2018;235:281\u20139.","journal-title":"Klin Monbl Augenheilkd"},{"key":"6392_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000520895","volume":"65","author":"HM Azhar Baig","year":"2022","unstructured":"Azhar Baig HM, Ansar M, Iqbal A, Naeem MA, Quinodoz M, Calzetti G, Iqbal M, Rivolta C. Genetic analysis of consanguineous Pakistani families with congenital stationary night blindness. Ophthalmic Res. 2022;65:104\u201310.","journal-title":"Ophthalmic Res"},{"key":"6392_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL. ISCEV standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol. 2022;144:165\u201377.","journal-title":"Doc Ophthalmol"},{"key":"6392_CR10","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/OPX.0b013e318155a94e","volume":"84","author":"MA Bearse","year":"2007","unstructured":"Bearse MA. Jr. Principles and practice of clinical electrophysiology of vision. Optom Vis Sci. 2007;84:825. 2nd ed.","journal-title":"Optom Vis Sci"},{"key":"6392_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4103\/ojo.ojo_220_22","volume":"16","author":"P Shanmugam","year":"2023","unstructured":"Shanmugam P, Mohankumar A, Mohan S, Rajan M, Leo J. Oguchi\u2019s disease - Clinical image. Oman J Ophthalmol. 2023;16:567\u20139.","journal-title":"Oman J Ophthalmol"},{"key":"6392_CR12","first-page":"1148","volume":"17","author":"G Mizuo","year":"1913","unstructured":"Mizuo G. On a new discovery in the dark adaptation of Oguchi\u2019s disease. Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn). 1913;17:1148\u201350.","journal-title":"Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn)"},{"key":"6392_CR13","first-page":"557","volume":"9","author":"P Gouras","year":"1970","unstructured":"Gouras P. Electroretinography: some basic principles. Invest Ophthalmol. 1970;9:557\u201369.","journal-title":"Invest Ophthalmol"},{"key":"6392_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/eye.2011.88","volume":"25","author":"PI Sergouniotis","year":"2011","unstructured":"Sergouniotis PI, Davidson AE, Sehmi K, Webster AR, Robson AG, Moore AT. Mizuo-Nakamura phenomenon in Oguchi disease due to a homozygous nonsense mutation in the SAG gene. Eye (Lond). 2011;25:1098\u2013101.","journal-title":"Eye (Lond)"},{"key":"6392_CR15","first-page":"511","volume":"40","author":"Y Miyake","year":"1996","unstructured":"Miyake Y, Horiguchi M, Suzuki S, Kondo M, Tanikawa A. Electrophysiological findings in patients with Oguchi\u2019s disease. Jpn J Ophthalmol. 1996;40:511\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"6392_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0002-9394(00)00737-6","volume":"130","author":"TP Dryja","year":"2000","unstructured":"Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson memorial lecture. Am J Ophthalmol. 2000;130:547\u201363.","journal-title":"Am J Ophthalmol"},{"key":"6392_CR17","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.ophtha.2010.12.031","volume":"118","author":"PI Sergouniotis","year":"2011","unstructured":"Sergouniotis PI, Sohn EH, Li Z, McBain VA, Wright GA, Moore AT, Robson AG, Holder GE, Webster AR. Phenotypic variability in RDH5 retinopathy (Fundus Albipunctatus). Ophthalmology. 2011;118:1661\u201370.","journal-title":"Ophthalmology"},{"key":"6392_CR18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000301211","volume":"123","author":"G Schubert","year":"2010","unstructured":"Schubert G, Bornschein H. Beitrag Zur analyse des menschlichen elektroretinogramms. Ophthalmologica. 2010;123:396\u2013413.","journal-title":"Ophthalmologica"},{"key":"6392_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preteyeres.2014.09.001","volume":"45","author":"C Zeitz","year":"2015","unstructured":"Zeitz C, Robson AG, Audo I. Congenital stationary night blindness: an analysis and update of genotype\u2013phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res. 2015;45:58\u2013110.","journal-title":"Prog Retin Eye Res"},{"key":"6392_CR20","doi-asserted-by":"publisher","first-page":"12047","DOI":"10.1038\/s41598-019-46811-7","volume":"9","author":"A AlTalbishi","year":"2019","unstructured":"AlTalbishi A, Zelinger L, Zeitz C, Hendler K, Namburi P, Audo I, Sheffer R, Yahalom C, Khateb S, Banin E, Sharon D. TRPM1 mutations are the most common cause of autosomal recessive congenital stationary night blindness (CSNB) in the Palestinian and Israeli populations. Sci Rep. 2019;9:12047.","journal-title":"Sci Rep"},{"key":"6392_CR21","first-page":"81","volume":"31","author":"Y Miyake","year":"1987","unstructured":"Miyake Y, Yagasaki K, Horiguchi M, Kawase Y. On- and off-responses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol. 1987;31:81\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"6392_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/archopht.1986.01050190071042","volume":"104","author":"Y Miyake","year":"1986","unstructured":"Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram: A new classification. Arch Ophthalmol. 1986;104:1013\u201320.","journal-title":"Arch Ophthalmol"},{"key":"6392_CR23","first-page":"737","volume":"106","author":"Y Miyake","year":"2002","unstructured":"Miyake Y. Establishment of the concept of new clinical entities\u2013complete and incomplete form of congenital stationary night blindness. Nippon Ganka Gakkai Zasshi. 2002;106:737\u201356.","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"6392_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10633-018-9645-y","volume":"136","author":"M Sustar","year":"2018","unstructured":"Sustar M, Holder GE, Kremers J, Barnes CS, Lei B, Khan NW, Robson AG. ISCEV extended protocol for the photopic On-Off ERG. Doc Ophthalmol. 2018;136:199\u2013206.","journal-title":"Doc Ophthalmol"},{"key":"6392_CR25","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.ophtha.2013.03.002","volume":"120","author":"MM Bijveld","year":"2013","unstructured":"Bijveld MM, Florijn RJ, Bergen AA, van den Born LI, Kamermans M, Prick L, Riemslag FC, van Schooneveld MJ, Kappers AM, van Genderen MM. Genotype and phenotype of 101 Dutch patients with congenital stationary night blindness. Ophthalmology. 2013;120:2072\u201381.","journal-title":"Ophthalmology"},{"key":"6392_CR26","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1111\/j.1755-3768.2011.02267.x","volume":"90","author":"PI Sergouniotis","year":"2012","unstructured":"Sergouniotis PI, Robson AG, Li Z, Devery S, Holder GE, Moore AT, Webster AR. A phenotypic study of congenital stationary night blindness (CSNB) associated with mutations in the GRM6 gene. Acta Ophthalmol. 2012;90:e192\u2013197.","journal-title":"Acta Ophthalmol"},{"key":"6392_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0002-9394(54)90011-2","volume":"38","author":"LA Riggs","year":"1954","unstructured":"Riggs LA. Electroretinography in cases of night blindness. Am J Ophthalmol. 1954;38:70\u20138.","journal-title":"Am J Ophthalmol"},{"key":"6392_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10633-018-9651-0","volume":"137","author":"MF Marmor","year":"2018","unstructured":"Marmor MF, Zeitz C. Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association. Doc Ophthalmol. 2018;137:57\u201362.","journal-title":"Doc Ophthalmol"},{"key":"6392_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/humu.9499","volume":"28","author":"V Szabo","year":"2007","unstructured":"Szabo V, Kreienkamp HJ, Rosenberg T, Gal A. p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Hum Mutat. 2007;28:741\u20132.","journal-title":"Hum Mutat"},{"key":"6392_CR30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1167\/iovs.11-8026","volume":"53","author":"MA Naeem","year":"2012","unstructured":"Naeem MA, Chavali VRM, Ali S, Iqbal M, Riazuddin S, Khan SN, Husnain T, Sieving PA, Ayyagari R, Riazuddin S, et al. GNAT1 associated with autosomal recessive congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2012;53:1353\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6392_CR31","doi-asserted-by":"publisher","first-page":"7694801","DOI":"10.1155\/2018\/7694801","volume":"2018","author":"C Zeitz","year":"2018","unstructured":"Zeitz C, M\u00e9j\u00e9case C, St\u00e9venard M, Michiels C, Audo I, Marmor MF. A novel heterozygous missense mutation in GNAT1 leads to autosomal dominant Riggs type of congenital stationary night blindness. Biomed Res Int. 2018;2018:7694801.","journal-title":"Biomed Res Int"},{"key":"6392_CR32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ajhg.2016.03.021","volume":"98","author":"A Vincent","year":"2016","unstructured":"Vincent A, Audo I, Tavares E, Maynes JT, Tumber A, Wright T, Li S, Michiels C, Condroyer C, MacDonald H, et al. Biallelic mutations in GNB3 cause a unique form of Autosomal-Recessive congenital stationary night blindness. Am J Hum Genet. 2016;98:1011\u20139.","journal-title":"Am J Hum Genet"},{"key":"6392_CR33","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jamaophthalmol.2016.1543","volume":"134","author":"G Arno","year":"2016","unstructured":"Arno G, Holder GE, Chakarova C, Kohl S, Pontikos N, Fiorentino A, Plagnol V, Cheetham ME, Hardcastle AJ, Webster AR, Michaelides M. Recessive retinopathy consequent on mutant G-Protein \u0392 subunit 3 (GNB3). JAMA Ophthalmol. 2016;134:924\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"6392_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.survophthal.2007.10.010","volume":"53","author":"I Audo","year":"2008","unstructured":"Audo I, Robson AG, Holder GE, Moore AT. The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol. 2008;53:16\u201340.","journal-title":"Surv Ophthalmol"},{"key":"6392_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/humu.20425","volume":"28","author":"SH Tsang","year":"2007","unstructured":"Tsang SH, Woodruff ML, Jun L, Mahajan V, Yamashita CK, Pedersen R, Lin CS, Goff SP, Rosenberg T, Larsen M, et al. Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness. Hum Mutat. 2007;28:243\u201354.","journal-title":"Hum Mutat"},{"key":"6392_CR36","doi-asserted-by":"crossref","unstructured":"Kobal N, Kra\u0161ovec T, \u0160u\u0161tar M, Volk M, Peterlin B, Hawlina M, Fakin A. Stationary and progressive phenotypes caused by the p.G90D mutation in rhodopsin gene. Int J Mol Sci. 2021;22:2133.","DOI":"10.3390\/ijms22042133"},{"key":"6392_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ajhg.2010.08.013","volume":"87","author":"SA Riazuddin","year":"2010","unstructured":"Riazuddin SA, Shahzadi A, Zeitz C, Ahmed ZM, Ayyagari R, Chavali VR, Ponferrada VG, Audo I, Michiels C, Lancelot ME, et al. A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet. 2010;87:523\u201331.","journal-title":"Am J Hum Genet"},{"key":"6392_CR38","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/cge.12746","volume":"89","author":"M Neuill\u00e9","year":"2016","unstructured":"Neuill\u00e9 M, Malaichamy S, Vadal\u00e0 M, Michiels C, Condroyer C, Sachidanandam R, Srilekha S, Arokiasamy T, Letexier M, D\u00e9montant V, et al. Next-generation sequencing confirms the implication of SLC24A1 in autosomal-recessive congenital stationary night blindness. Clin Genet. 2016;89:690\u20139.","journal-title":"Clin Genet"},{"key":"6392_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ng0796-358","volume":"13","author":"TP Dryja","year":"1996","unstructured":"Dryja TP, Hahn LB, Reboul T, Arnaud B. Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996;13:358\u201360.","journal-title":"Nat Genet"},{"key":"6392_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/hmg\/3.2.323","volume":"3","author":"A Gal","year":"1994","unstructured":"Gal A, Xu S, Piczenik Y, Eiberg H, Duvigneau C, Schwinger E, Rosenberg T. Gene for autosomal dominant congenital stationary night blindness maps to the same region as the gene for the beta-subunit of the rod photoreceptor cGMP phosphodiesterase (PDEB) in chromosome 4p16.3. Hum Mol Genet. 1994;3:323\u20135.","journal-title":"Hum Mol Genet"},{"key":"6392_CR41","doi-asserted-by":"publisher","first-page":"e95768","DOI":"10.1371\/journal.pone.0095768","volume":"9","author":"G Manes","year":"2014","unstructured":"Manes G, Cheguru P, Majumder A, Bocquet B, S\u00e9n\u00e9chal A, Artemyev NO, Hamel CP, Brabet P. A truncated form of rod photoreceptor PDE6 \u03b2-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the \u03b3-subunit. PLoS ONE. 2014;9:e95768.","journal-title":"PLoS ONE"},{"key":"6392_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2004.08.008","volume":"104","author":"T Sch\u00f6neberg","year":"2004","unstructured":"Sch\u00f6neberg T, Schulz A, Biebermann H, Hermsdorf T, R\u00f6mpler H, Sangkuhl K. Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther. 2004;104:173\u2013206.","journal-title":"Pharmacol Ther"},{"key":"6392_CR43","first-page":"1183772","volume":"2022","author":"H You","year":"2022","unstructured":"You H, Sierpina D. A novel pathogenic variant in the RDH5 gene in a patient with fundus albipunctatus and severe macular atrophy. Case Rep Genet. 2022;2022:1183772.","journal-title":"Case Rep Genet"},{"key":"6392_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/ng0795-360","volume":"10","author":"S Fuchs","year":"1995","unstructured":"Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet. 1995;10:360\u20132.","journal-title":"Nat Genet"},{"key":"6392_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0297-175","volume":"15","author":"S Yamamoto","year":"1997","unstructured":"Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet. 1997;15:175\u20138.","journal-title":"Nat Genet"},{"key":"6392_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/cne.902930104","volume":"293","author":"P Ahnelt","year":"1990","unstructured":"Ahnelt P, Keri C, Kolb H. Identification of pedicles of putative blue-sensitive cones in the human retina. J Comp Neurol. 1990;293:39\u201353.","journal-title":"J Comp Neurol"},{"key":"6392_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0896-6273(00)00011-8","volume":"27","author":"S Haverkamp","year":"2000","unstructured":"Haverkamp S, Gr\u00fcnert U, W\u00e4ssle H. The cone pedicle, a complex synapse in the retina. Neuron. 2000;27:85\u201395.","journal-title":"Neuron"},{"key":"6392_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrn1497","volume":"5","author":"H W\u00e4ssle","year":"2004","unstructured":"W\u00e4ssle H. Parallel processing in the mammalian retina. Nat Rev Neurosci. 2004;5:747\u201357.","journal-title":"Nat Rev Neurosci"},{"key":"6392_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-vision-102016-061345","volume":"3","author":"JS Diamond","year":"2017","unstructured":"Diamond JS. Inhibitory interneurons in the retina: types, circuitry, and function. Annu Rev Vis Sci. 2017;3:1\u201324.","journal-title":"Annu Rev Vis Sci"},{"key":"6392_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/940","volume":"19","author":"TM Strom","year":"1998","unstructured":"Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, R\u00fcther K, Drescher B, et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19:260\u20133.","journal-title":"Nat Genet"},{"key":"6392_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/947","volume":"19","author":"NT Bech-Hansen","year":"1998","unstructured":"Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19:264\u20137.","journal-title":"Nat Genet"},{"key":"6392_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1086\/508067","volume":"79","author":"C Zeitz","year":"2006","unstructured":"Zeitz C, Kloeckener-Gruissem B, Forster U, Kohl S, Magyar I, Wissinger B, M\u00e1ty\u00e1s G, Borruat FX, Schorderet DF, Zrenner E, et al. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet. 2006;79:657\u201367.","journal-title":"Am J Hum Genet"},{"key":"6392_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/humu.23735","volume":"40","author":"C Zeitz","year":"2019","unstructured":"Zeitz C, Michiels C, Neuill\u00e9 M, Friedburg C, Condroyer C, Boyard F, Antonio A, Bouzidi N, Milicevic D, Veaux R, et al. Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F-mediated inherited retinal disorders. Hum Mutat. 2019;40:765\u201387.","journal-title":"Hum Mutat"},{"key":"6392_CR54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","volume":"16","author":"WA Catterall","year":"2000","unstructured":"Catterall WA. Structure and regulation of voltage-gated Ca2\u2009+\u2009channels. Annu Rev Cell Dev Biol. 2000;16:521\u201355.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"6392_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0959-4388(03)00066-7","volume":"13","author":"J Arikkath","year":"2003","unstructured":"Arikkath J, Campbell KP. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol. 2003;13:298\u2013307.","journal-title":"Curr Opin Neurobiol"},{"key":"6392_CR56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0896-6273(00)80061-6","volume":"16","author":"CA Gurnett","year":"1996","unstructured":"Gurnett CA, De Waard M, Campbell KP. Dual function of the voltage-dependent Ca2\u2009+\u2009channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron. 1996;16:431\u201340.","journal-title":"Neuron"},{"key":"6392_CR57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1152\/jn.00482.2002","volume":"89","author":"H Song","year":"2003","unstructured":"Song H, Nie L, Rodriguez-Contreras A, Sheng ZH, Yamoah EN. Functional interaction of auxiliary subunits and synaptic proteins with Ca(v)1.3 May impart hair cell Ca2\u2009+\u2009current properties. J Neurophysiol. 2003;89:1143\u20139.","journal-title":"J Neurophysiol"},{"key":"6392_CR58","doi-asserted-by":"publisher","first-page":"36312","DOI":"10.1074\/jbc.M112.392811","volume":"287","author":"L Shaltiel","year":"2012","unstructured":"Shaltiel L, Paparizos C, Fenske S, Hassan S, Gruner C, R\u00f6tzer K, Biel M, Wahl-Schott CA. Complex regulation of voltage-dependent activation and inactivation properties of retinal voltage-gated Cav1.4 L-type Ca2\u2009+\u2009channels by Ca2+-binding protein 4 (CaBP4). J Biol Chem. 2012;287:36312\u201321.","journal-title":"J Biol Chem"},{"key":"6392_CR59","doi-asserted-by":"publisher","first-page":"11868","DOI":"10.1016\/S0021-9258(19)50280-0","volume":"268","author":"Y Nakajima","year":"1993","unstructured":"Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N, Nakanishi S. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem. 1993;268:11868\u201373.","journal-title":"J Biol Chem"},{"key":"6392_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0092-8674(94)90151-1","volume":"77","author":"A Nomura","year":"1994","unstructured":"Nomura A, Shigemoto R, Nakamura Y, Okamoto N, Mizuno N, Nakanishi S. Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells. Cell. 1994;77:361\u20139.","journal-title":"Cell"},{"key":"6392_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/0092-8674(95)90354-2","volume":"80","author":"M Masu","year":"1995","unstructured":"Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, Fukuda Y, Sasaki H, Hiroi K, Nakamura Y, Shigemoto R, et al. Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell. 1995;80:757\u201365.","journal-title":"Cell"},{"key":"6392_CR62","doi-asserted-by":"publisher","first-page":"19174","DOI":"10.1073\/pnas.0908711106","volume":"106","author":"CW Morgans","year":"2009","unstructured":"Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci U S A. 2009;106:19174\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR63","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.1523\/JNEUROSCI.0132-09.2009","volume":"29","author":"Y Shen","year":"2009","unstructured":"Shen Y, Heimel JA, Kamermans M, Peachey NS, Gregg RG, Nawy S. A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. J Neurosci. 2009;29:6088\u201393.","journal-title":"J Neurosci"},{"key":"6392_CR64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1073\/pnas.0912730107","volume":"107","author":"C Koike","year":"2010","unstructured":"Koike C, Obara T, Uriu Y, Numata T, Sanuki R, Miyata K, Koyasu T, Ueno S, Funabiki K, Tani A, et al. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A. 2010;107:332\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR65","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0042-6989(97)00176-4","volume":"38","author":"JH Brandst\u00e4tter","year":"1998","unstructured":"Brandst\u00e4tter JH, Koulen P, W\u00e4ssle H. Diversity of glutamate receptors in the mammalian retina. Vis Res. 1998;38:1385\u201397.","journal-title":"Vis Res"},{"key":"6392_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.03.054","volume":"243","author":"C Puller","year":"2013","unstructured":"Puller C, Ivanova E, Euler T, Haverkamp S, Schubert T. OFF bipolar cells express distinct types of dendritic glutamate receptors in the mouse retina. Neuroscience. 2013;243:136\u201348.","journal-title":"Neuroscience"},{"key":"6392_CR67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1113\/JP271458","volume":"594","author":"T Ichinose","year":"2016","unstructured":"Ichinose T, Hellmer CB. Differential signalling and glutamate receptor compositions in the OFF bipolar cell types in the mouse retina. J Physiol. 2016;594:883\u201394.","journal-title":"J Physiol"},{"key":"6392_CR68","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1523\/JNEUROSCI.19-08-02938.1999","volume":"19","author":"S Nawy","year":"1999","unstructured":"Nawy S. The metabotropic receptor mGluR6 May signal through G(o), but not phosphodiesterase, in retinal bipolar cells. J Neurosci. 1999;19:2938\u201344.","journal-title":"J Neurosci"},{"key":"6392_CR69","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1523\/JNEUROSCI.1014-11.2011","volume":"31","author":"JN Pearring","year":"2011","unstructured":"Pearring JN, Bojang P Jr., Shen Y, Koike C, Furukawa T, Nawy S, Gregg RG. A role for Nyctalopin, a small leucine-rich repeat protein, in localizing the TRP melastatin 1 channel to retinal depolarizing bipolar cell dendrites. J Neurosci. 2011;31:10060\u20136.","journal-title":"J Neurosci"},{"key":"6392_CR70","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/ejn.12959","volume":"42","author":"M Neuill\u00e9","year":"2015","unstructured":"Neuill\u00e9 M, Morgans CW, Cao Y, Orhan E, Michiels C, Sahel JA, Audo I, Duvoisin RM, Martemyanov KA, Zeitz C. LRIT3 is essential to localize TRPM1 to the dendritic tips of depolarizing bipolar cells and May play a role in cone synapse formation. Eur J Neurosci. 2015;42:1966\u201375.","journal-title":"Eur J Neurosci"},{"key":"6392_CR71","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ajhg.2009.10.012","volume":"85","author":"MM van Genderen","year":"2009","unstructured":"van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet. 2009;85:730\u20136.","journal-title":"Am J Hum Genet"},{"key":"6392_CR72","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1523\/JNEUROSCI.4044-13.2014","volume":"34","author":"TA Ray","year":"2014","unstructured":"Ray TA, Heath KM, Hasan N, Noel JM, Samuels IS, Martemyanov KA, Peachey NS, McCall MA, Gregg RG. GPR179 is required for high sensitivity of the mGluR6 signaling cascade in depolarizing bipolar cells. J Neurosci. 2014;34:6334\u201343.","journal-title":"J Neurosci"},{"key":"6392_CR73","doi-asserted-by":"publisher","first-page":"11343","DOI":"10.1523\/JNEUROSCI.1436-12.2012","volume":"32","author":"A Dhingra","year":"2012","unstructured":"Dhingra A, Ramakrishnan H, Neinstein A, Fina ME, Xu Y, Li J, Chung DC, Lyubarsky A, Vardi N. G\u03b23 is required for normal light ON responses and synaptic maintenance. J Neurosci. 2012;32:11343\u201355.","journal-title":"J Neurosci"},{"key":"6392_CR74","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1167\/iovs.06-0271","volume":"47","author":"KA Wycisk","year":"2006","unstructured":"Wycisk KA, Budde B, Feil S, Skosyrski S, Buzzi F, Neidhardt J, Glaus E, N\u00fcrnberg P, Ruether K, Berger W. Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Invest Ophthalmol Vis Sci. 2006;47:3523\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6392_CR75","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.visres.2009.04.008","volume":"49","author":"W Baehr","year":"2009","unstructured":"Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res. 2009;49:2636\u201352.","journal-title":"Vis Res"},{"key":"6392_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11434-013-0032-5","volume":"59","author":"RY Chen-Tsai","year":"2014","unstructured":"Chen-Tsai RY, Jiang R, Zhuang L, Wu J, Li L, Wu J. Genome editing and animal models. Chin Sci Bull. 2014;59:1\u20136.","journal-title":"Chin Sci Bull"},{"key":"6392_CR77","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrg3116","volume":"13","author":"A Devoy","year":"2012","unstructured":"Devoy A, Bunton-Stasyshyn RKA, Tybulewicz VLJ, Smith AJH, Fisher EMC. Genomically humanized mice: technologies and promises. Nat Rev Genet. 2012;13:14\u201320.","journal-title":"Nat Rev Genet"},{"key":"6392_CR78","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.drudis.2013.07.007","volume":"18","author":"N Scheer","year":"2013","unstructured":"Scheer N, Snaith M, Wolf CR, Seibler J. Generation and utility of genetically humanized mouse models. Drug Discov Today. 2013;18:1200\u201311.","journal-title":"Drug Discov Today"},{"key":"6392_CR79","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/hmg\/ddab316","volume":"31","author":"LM Occelli","year":"2022","unstructured":"Occelli LM, Daruwalla A, De Silva SR, Winkler PA, Sun K, Pasmanter N, Minella A, Querubin J, Lyons LA, Robson AG, et al. A large animal model of RDH5-associated retinopathy recapitulates important features of the human phenotype. Hum Mol Genet. 2022;31:1263\u201377.","journal-title":"Hum Mol Genet"},{"key":"6392_CR80","doi-asserted-by":"publisher","first-page":"14166","DOI":"10.1038\/s41598-019-50573-7","volume":"9","author":"RG Das","year":"2019","unstructured":"Das RG, Becker D, Jagannathan V, Goldstein O, Santana E, Carlin K, Sudharsan R, Leeb T, Nishizawa Y, Kondo M, et al. Genome-wide association study and whole-genome sequencing identify a deletion in LRIT3 associated with canine congenital stationary night blindness. Sci Rep. 2019;9:14166.","journal-title":"Sci Rep"},{"key":"6392_CR81","first-page":"1871","volume":"19","author":"O Goldstein","year":"2013","unstructured":"Goldstein O, Jordan JA, Aguirre GD, Acland GM. A non-stop S-antigen gene mutation is associated with late onset hereditary retinal degeneration in dogs. Mol Vis. 2013;19:1871\u201384.","journal-title":"Mol Vis"},{"key":"6392_CR82","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/ijms25020899","volume":"25","author":"W Chen","year":"2024","unstructured":"Chen W, Zhong W, Yu L, Lin X, Xie J, Liu Z. A drosophila model reveals the potential role for Mtt in retinal disease. Int J Mol Sci. 2024;25:899.","journal-title":"Int J Mol Sci"},{"key":"6392_CR83","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/evj.13318","volume":"53","author":"YL Hack","year":"2021","unstructured":"Hack YL, Crabtree EE, Avila F, Sutton RB, Grahn R, Oh A, Gilger B, Bellone RR. Whole-genome sequencing identifies missense mutation in GRM6 as the likely cause of congenital stationary night blindness in a Tennessee walking horse. Equine Vet J. 2021;53:316\u201323.","journal-title":"Equine Vet J"},{"key":"6392_CR84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2052.2010.02119.x","volume":"41","author":"RR Bellone","year":"2010","unstructured":"Bellone RR, Archer S, Wade CM, Cuka-Lawson C, Haase B, Leeb T, Forsyth G, Sandmeyer L, Grahn B. Association analysis of candidate SNPs in TRPM1 with Leopard complex spotting (LP\u200a) and congenital stationary night blindness (CSNB) in horses. Anim Genet. 2010;41:207\u2013207.","journal-title":"Anim Genet"},{"key":"6392_CR85","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.3390\/ijms22094424","volume":"22","author":"E Orhan","year":"2021","unstructured":"Orhan E, Neuill\u00e9 M, de Sousa Dias M, Pugliese T, Michiels C, Condroyer C, Antonio A, Sahel J-A, Audo I, Zeitz C. A new mouse model for complete congenital stationary night blindness due to Gpr179 deficiency. Int J Mol Sci. 2021;22:4424.","journal-title":"Int J Mol Sci"},{"key":"6392_CR86","doi-asserted-by":"publisher","first-page":"e90342","DOI":"10.1371\/journal.pone.0090342","volume":"9","author":"M Neuill\u00e9","year":"2014","unstructured":"Neuill\u00e9 M, El Shamieh S, Orhan E, Michiels C, Antonio A, Lancelot ME, Condroyer C, Bujakowska K, Poch O, Sahel JA, et al. Lrit3 deficient mouse (nob6): a novel model of complete congenital stationary night blindness (cCSNB). PLoS ONE. 2014;9:e90342.","journal-title":"PLoS ONE"},{"key":"6392_CR87","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.exer.2018.11.010","volume":"179","author":"X Dai","year":"2019","unstructured":"Dai X, Pang S, Wang J, FitzMaurice B, Pang J, Chang B. Photoreceptor degeneration in a new Cacna1f mutant mouse model. Exp Eye Res. 2019;179:106\u201314.","journal-title":"Exp Eye Res"},{"key":"6392_CR88","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/jn.00888.2016","volume":"118","author":"NS Peachey","year":"2017","unstructured":"Peachey NS, Hasan N, FitzMaurice B, Burrill S, Pangeni G, Karst SY, Reinholdt L, Berry ML, Strobel M, Gregg RG, et al. A missense mutation in Grm6 reduces but does not eliminate mGluR6 expression or rod depolarizing bipolar cell function. J Neurophysiol. 2017;118:845\u201354.","journal-title":"J Neurophysiol"},{"key":"6392_CR89","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1523\/JNEUROSCI.21-15-05449.2001","volume":"21","author":"PA Sieving","year":"2001","unstructured":"Sieving PA, Fowler ML, Bush RA, Machida S, Calvert PD, Green DG, Makino CL, McHenry CL. Constitutive light adaptation in rods from G90D rhodopsin: A mechanism for human congenital nightblindness without rod cell loss. J Neurosci. 2001;21:5449\u201360.","journal-title":"J Neurosci"},{"key":"6392_CR90","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1523\/JNEUROSCI.1322-06.2006","volume":"26","author":"M Moussaif","year":"2006","unstructured":"Moussaif M, Rubin WW, Kerov V, Reh R, Chen D, Lem J, Chen C-K, Hurley JB, Burns ME, Artemyev NO. Phototransduction in a Transgenic mouse model of Nougaret night blindness. J Neurosci. 2006;26:6863\u201372.","journal-title":"J Neurosci"},{"key":"6392_CR91","doi-asserted-by":"publisher","first-page":"41069","DOI":"10.1074\/jbc.M508849200","volume":"280","author":"V Kerov","year":"2005","unstructured":"Kerov V, Chen D, Moussaif M, Chen Y-J, Chen C-K, Artemyev NO. Transducin activation state controls its Light-dependent translocation in rod photoreceptors. J Biol Chem. 2005;280:41069\u201376.","journal-title":"J Biol Chem"},{"key":"6392_CR92","doi-asserted-by":"publisher","first-page":"13913","DOI":"10.1073\/pnas.250478897","volume":"97","author":"PD Calvert","year":"2000","unstructured":"Calvert PD, Krasnoperova NV, Lyubarsky AL, Isayama T, Nicolo M, Kosaras B, Wong G, Gannon KS, Margolskee RF, Sidman RL. Phototransduction in Transgenic mice after targeted deletion of the rod transducin \u03b1-subunit. Proc Natl Acad Sci U S A. 2000;97:13913\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR93","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1128\/MCB.20.12.4275-4287.2000","volume":"20","author":"CA Driessen","year":"2000","unstructured":"Driessen CA, Winkens HJ, Hoffmann K, Kuhlmann LD, Janssen BP, Van Vugt AH, Van Hooser JP, Wieringa BE, Deutman AF, Palczewski K, et al. Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters. Mol Cell Biol. 2000;20:4275\u201387.","journal-title":"Mol Cell Biol"},{"key":"6392_CR94","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1073\/pnas.96.7.3718","volume":"96","author":"CK Chen","year":"1999","unstructured":"Chen CK, Burns ME, Spencer M, Niemi GA, Chen J, Hurley JB, Baylor DA, Simon MI. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci U S A. 1999;96:3718\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR95","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/hmg\/ddi336","volume":"14","author":"F Mansergh","year":"2005","unstructured":"Mansergh F, Orton NC, Vessey JP, Lalonde MR, Stell WK, Tremblay F, Barnes S, Rancourt DE, Bech-Hansen NT. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum Mol Genet. 2005;14:3035\u201346.","journal-title":"Hum Mol Genet"},{"key":"6392_CR96","doi-asserted-by":"publisher","first-page":"e2538","DOI":"10.1371\/journal.pone.0002538","volume":"3","author":"CJ Doering","year":"2008","unstructured":"Doering CJ, Rehak R, Bonfield S, Peloquin JB, Stell WK, Mema SC, Sauv\u00e9 Y, McRory JE. Modified Cav1.4 expression in the Cacna1fnob2 mouse due to alternative splicing of an ETn inserted in exon 2. PLoS ONE. 2008;3:e2538.","journal-title":"PLoS ONE"},{"key":"6392_CR97","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/hmg\/ddt541","volume":"23","author":"S Michalakis","year":"2013","unstructured":"Michalakis S, Shaltiel L, Sothilingam V, Koch S, Schludi V, Krause S, Zeitz C, Audo I, Lancelot M-E, Hamel C, et al. Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Hum Mol Genet. 2013;23:1538\u201350.","journal-title":"Hum Mol Genet"},{"key":"6392_CR98","doi-asserted-by":"publisher","first-page":"503","DOI":"10.4161\/chan.26368","volume":"7","author":"D Knoflach","year":"2013","unstructured":"Knoflach D, Kerov V, Sartori SB, Obermair GJ, Schmuckermair C, Liu X, Sothilingam V, Garrido MG, Baker SA, Gl\u00f6smann M, et al. Cav1.4 IT mouse as model for vision impairment in human congenital stationary night blindness type 2. Channels. 2013;7:503\u201313.","journal-title":"Channels"},{"key":"6392_CR99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nn1320","volume":"7","author":"F Haeseleer","year":"2004","unstructured":"Haeseleer F, Imanishi Y, Maeda T, Possin DE, Maeda A, Lee A, Rieke F, Palczewski K. Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci. 2004;7:1079\u201387.","journal-title":"Nat Neurosci"},{"key":"6392_CR100","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1152\/jn.00137.2012","volume":"108","author":"NS Peachey","year":"2012","unstructured":"Peachey NS, Pearring JN, Bojang P Jr., Hirschtritt ME, Sturgill-Short G, Ray TA, Furukawa T, Koike C, Goldberg AF, Shen Y, et al. Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation. J Neurophysiol. 2012;108:2442\u201351.","journal-title":"J Neurophysiol"},{"key":"6392_CR101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/02713680701823232","volume":"33","author":"T Koyasu","year":"2008","unstructured":"Koyasu T, Kondo M, Miyata K, Ueno S, Miyata T, Nishizawa Y, Terasaki H. Photopic electroretinograms of mGluR6-deficient mice. Curr Eye Res. 2008;33:91\u20139.","journal-title":"Curr Eye Res"},{"key":"6392_CR102","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1113\/jphysiol.2008.157289","volume":"586","author":"DM Maddox","year":"2008","unstructured":"Maddox DM, Vessey KA, Yarbrough GL, Invergo BM, Cantrell DR, Inayat S, Balannik V, Hicks WL, Hawes NL, Byers S, et al. Allelic variance between GRM6 mutants, Grm6nob3 and Grm6nob4 results in differences in retinal ganglion cell visual responses. J Physiol. 2008;586:4409\u201324.","journal-title":"J Physiol"},{"key":"6392_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ajhg.2011.12.006","volume":"90","author":"S Peachey Neal","year":"2012","unstructured":"Peachey Neal S, Ray Thomas A, Florijn R, Rowe Lucy B, Sjoerdsma T, Contreras-Alcantara S, Baba K, Tosini G, Pozdeyev N, Iuvone PM, et al. GPR179 is required for depolarizing bipolar cell function and is mutated in Autosomal-Recessive complete congenital stationary night blindness. Am J Hum Genet. 2012;90:331\u20139.","journal-title":"Am J Hum Genet"},{"key":"6392_CR104","doi-asserted-by":"publisher","first-page":"E004","DOI":"10.1017\/S0952523815000012","volume":"32","author":"H Qian","year":"2015","unstructured":"Qian H, Ji R, Gregg RG, Peachey NS. Identification of a new mutant allele, Grm6(nob7), for complete congenital stationary night blindness. Vis Neurosci. 2015;32:E004.","journal-title":"Vis Neurosci"},{"key":"6392_CR105","doi-asserted-by":"publisher","first-page":"e2404763121","DOI":"10.1073\/pnas.2404763121","volume":"121","author":"Z Chai","year":"2024","unstructured":"Chai Z, Ye Y, Silverman D, Rose K, Madura A, Reed RR, Chen J, Yau K-W. Dark continuous noise from mutant G90D-rhodopsin predominantly underlies congenital stationary night blindness. Proc Natl Acad Sci U S A. 2024;121:e2404763121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR106","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/01677063.2012.684416","volume":"26","author":"J An","year":"2012","unstructured":"An J, Wang L, Guo Q, Li L, Xia F, Zhang Z. Behavioral phenotypic properties of a natural occurring rat model of congenital stationary night blindness with Cacna1f mutation. J Neurogenet. 2012;26:363\u201373.","journal-title":"J Neurogenet"},{"key":"6392_CR107","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/hmg\/ddu009","volume":"23","author":"S Jia","year":"2014","unstructured":"Jia S, Muto A, Orisme W, Henson HE, Parupalli C, Ju B, Baier H, Taylor MR. Zebrafish Cacna1fa is required for cone photoreceptor function and synaptic ribbon formation. Hum Mol Genet. 2014;23:2981\u201394.","journal-title":"Hum Mol Genet"},{"key":"6392_CR108","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1371\/journal.pgen.0010066","volume":"1","author":"A Muto","year":"2005","unstructured":"Muto A, Orger MB, Wehman AM, Smear MC, Kay JN, Page-McCaw PS, Gahtan E, Xiao T, Nevin LM, Gosse NJ, et al. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet. 2005;1:e66.","journal-title":"PLoS Genet"},{"key":"6392_CR109","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1111\/j.1460-9568.2006.05053.x","volume":"24","author":"R Bahadori","year":"2006","unstructured":"Bahadori R, Biehlmaier O, Zeitz C, Labhart T, Makhankov YV, Forster U, Gesemann M, Berger W, Neuhauss SCF. Nyctalopin is essential for synaptic transmission in the cone dominated zebrafish retina. Eur J Neurosci. 2006;24:1664\u201374.","journal-title":"Eur J Neurosci"},{"key":"6392_CR110","doi-asserted-by":"publisher","first-page":"e35256","DOI":"10.1371\/journal.pone.0035256","volume":"7","author":"Y-Y Huang","year":"2012","unstructured":"Huang Y-Y, Haug MF, Gesemann M, Neuhauss SCF. Novel expression patterns of metabotropic glutamate receptor 6 in the zebrafish nervous system. PLoS ONE. 2012;7:e35256.","journal-title":"PLoS ONE"},{"key":"6392_CR111","first-page":"179","volume":"11","author":"M Whalen","year":"2024","unstructured":"Whalen M, Akula M, McNamee SM, DeAngelis MM, Haider NB. Seeing the future: A review of ocular therapy. Bioeng (Basel). 2024;11:179.","journal-title":"Bioeng (Basel)"},{"key":"6392_CR112","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/14712598.2022.2090241","volume":"22","author":"OG Segurado","year":"2022","unstructured":"Segurado OG, Jiang R, Pipe SW. Challenges and opportunities when transitioning from in vivo gene replacement to in vivo CRISPR\/Cas9 therapies - a spotlight on hemophilia. Expert Opin Biol Ther. 2022;22:1091\u20138.","journal-title":"Expert Opin Biol Ther"},{"key":"6392_CR113","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262\u201378.","journal-title":"Cell"},{"key":"6392_CR114","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nbt.2842","volume":"32","author":"JD Sander","year":"2014","unstructured":"Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32:347\u201355.","journal-title":"Nat Biotechnol"},{"key":"6392_CR115","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.","journal-title":"Science"},{"key":"6392_CR116","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DB Cox","year":"2015","unstructured":"Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21:121\u201331.","journal-title":"Nat Med"},{"key":"6392_CR117","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.tig.2008.08.007","volume":"24","author":"M McVey","year":"2008","unstructured":"McVey M, Lee SE. MMEJ repair of double-strand breaks (director\u2019s cut): deleted sequences and alternative endings. Trends Genet. 2008;24:529\u201338.","journal-title":"Trends Genet"},{"key":"6392_CR118","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature. 2016;540:144\u20139.","journal-title":"Nature"},{"key":"6392_CR119","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41422-019-0213-0","volume":"29","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Yamamoto M, Hernandez-Benitez R, Li Z, Wei C, Soligalla RD, Aizawa E, Hatanaka F, Kurita M, Reddy P, et al. Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction. Cell Res. 2019;29:804\u201319.","journal-title":"Cell Res"},{"key":"6392_CR120","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420\u20134.","journal-title":"Nature"},{"key":"6392_CR121","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature. 2017;551:464\u201371.","journal-title":"Nature"},{"key":"6392_CR122","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38:824\u201344.","journal-title":"Nat Biotechnol"},{"key":"6392_CR123","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","volume":"187","author":"M Pacesa","year":"2024","unstructured":"Pacesa M, Pelea O, Jinek M. Past, present, and future of CRISPR genome editing technologies. Cell. 2024;187:1076\u2013100.","journal-title":"Cell"},{"key":"6392_CR124","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1038\/s41467-024-49343-5","volume":"15","author":"H Tong","year":"2024","unstructured":"Tong H, Wang H, Wang X, Liu N, Li G, Wu D, Li Y, Jin M, Li H, Wei Y, et al. Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase. Nat Commun. 2024;15:4897.","journal-title":"Nat Commun"},{"key":"6392_CR125","doi-asserted-by":"publisher","first-page":"108192","DOI":"10.1016\/j.visres.2023.108192","volume":"206","author":"AL Yan","year":"2023","unstructured":"Yan AL, Du SW, Palczewski K. Genome editing, a superior therapy for inherited retinal diseases. Vis Res. 2023;206:108192.","journal-title":"Vis Res"},{"key":"6392_CR126","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","volume":"186","author":"JL Doman","year":"2023","unstructured":"Doman JL, Pandey S, Neugebauer ME, An M, Davis JR, Randolph PB, McElroy A, Gao XD, Raguram A, Richter MF, et al. Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell. 2023;186:3983\u20134002. e3926.","journal-title":"Cell"},{"key":"6392_CR127","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1016\/S1525-0016(16)34296-4","volume":"23","author":"ML Maeder","year":"2015","unstructured":"Maeder ML, Shen S, Burnight ER, Gloskowski S, Mepani R, Friedland AE, Jayaram H, Gotta G, Tucker BA, Bumcrot D. 687. Therapeutic correction of an LCA-Causing splice defect in the CEP290 gene by CRISPR\/Cas-Mediated genome editing. Mol Ther. 2015;23:S273\u20134.","journal-title":"Mol Ther"},{"key":"6392_CR128","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","volume":"390","author":"EA Pierce","year":"2024","unstructured":"Pierce EA, Aleman TS, Jayasundera KT, Ashimatey BS, Kim K, Rashid A, Jaskolka MC, Myers RL, Lam BL, Bailey ST. Gene editing for CEP290-associated retinal degeneration. N Engl J Med. 2024;390:1972\u201384.","journal-title":"N Engl J Med"},{"key":"6392_CR129","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.mcp.2025.102008","volume":"79","author":"V Szab\u00f3","year":"2025","unstructured":"Szab\u00f3 V, Vars\u00e1nyi B, Barboni M, Tak\u00e1cs \u00c1, Kn\u00e9zy K, Moln\u00e1r MJ, Nagy ZZ, Gy\u00f6rgy B, Rivolta C. Insights into eye genetics and recent advances in ocular gene therapy. Mol Cell Probes. 2025;79:102008.","journal-title":"Mol Cell Probes"},{"key":"6392_CR130","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/13543784.2020.1804853","volume":"29","author":"K Xue","year":"2020","unstructured":"Xue K, MacLaren RE. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases. Expert Opin Investig Drugs. 2020;29:1163\u201370.","journal-title":"Expert Opin Investig Drugs"},{"key":"6392_CR131","doi-asserted-by":"publisher","first-page":"e1594","DOI":"10.1002\/wrna.1594","volume":"11","author":"AM Quemener","year":"2020","unstructured":"Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD. The powerful world of antisense oligonucleotides: from bench to bedside. Wiley Interdiscip Rev RNA. 2020;11:e1594.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"6392_CR132","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1093\/nar\/gkae686","volume":"52","author":"I V\u00e1zquez-Dom\u00ednguez","year":"2024","unstructured":"V\u00e1zquez-Dom\u00ednguez I, Anido AA, Duijkers L, Hoppenbrouwers T, Hoogendoorn ADM, Koster C, Collin RWJ, Garanto A. Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina. Nucleic Acids Res. 2024;52:10447\u201363.","journal-title":"Nucleic Acids Res"},{"key":"6392_CR133","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","volume":"28","author":"SR Russell","year":"2022","unstructured":"Russell SR, Drack AV, Cideciyan AV, Jacobson SG, Leroy BP, Van Cauwenbergh C, Ho AC, Dumitrescu AV, Han IC, Martin M, et al. Intravitreal antisense oligonucleotide Sepofarsen in leber congenital amaurosis type 10: a phase 1b\/2 trial. Nat Med. 2022;28:1014\u201321.","journal-title":"Nat Med"},{"key":"6392_CR134","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","volume":"22","author":"X Chi","year":"2017","unstructured":"Chi X, Gatti P, Papoian T. Safety of antisense oligonucleotide and siRNA-based therapeutics. Drug Discov Today. 2017;22:823\u201333.","journal-title":"Drug Discov Today"},{"key":"6392_CR135","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14712598.2021.1856365","volume":"21","author":"MC Gemayel","year":"2021","unstructured":"Gemayel MC, Bhatwadekar AD, Ciulla T. RNA therapeutics for retinal diseases. Expert Opin Biol Ther. 2021;21:603\u201313.","journal-title":"Expert Opin Biol Ther"},{"key":"6392_CR136","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10633-024-09998-3","volume":"150","author":"L Wen","year":"2024","unstructured":"Wen L, Liu Y, Yang Z, Mei S, Xin Y, Li S. Novel CACNA1F pathogenic variant in pediatric incomplete X-linked CSNB: integrating portable ERG and genetic analysis. Doc Ophthalmol. 2024;150:33\u20139.","journal-title":"Doc Ophthalmol"},{"key":"6392_CR137","doi-asserted-by":"publisher","first-page":"e27039","DOI":"10.1016\/j.heliyon.2024.e27039","volume":"10","author":"D Bai","year":"2024","unstructured":"Bai D, Guo R, Huang D, Ji J, Liu W. Compound heterozygous mutations in GRM6 causing complete Schubert-Bornschein type congenital stationary night blindness. Heliyon. 2024;10:e27039.","journal-title":"Heliyon"},{"key":"6392_CR138","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaophthalmol.2022.4146","volume":"140","author":"VM Smirnov","year":"2022","unstructured":"Smirnov VM, Robert MP, Condroyer C, Navarro J, Antonio A, Rozet JM, Sahel JA, Perrault I, Audo I, Zeitz C. Association of missense variants in VSX2 with a peculiar form of congenital stationary night blindness affecting all bipolar cells. JAMA Ophthalmol. 2022;140:1163\u201373.","journal-title":"JAMA Ophthalmol"},{"key":"6392_CR139","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4103\/1673-5374.306063","volume":"16","author":"M Ross","year":"2021","unstructured":"Ross M, Ofri R. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery. Neural Regen Res. 2021;16:1751\u20139.","journal-title":"Neural Regen Res"},{"key":"6392_CR140","first-page":"1760","volume":"14","author":"Q Li","year":"2008","unstructured":"Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis. 2008;14:1760\u20139.","journal-title":"Mol Vis"},{"key":"6392_CR141","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/gt.2014.115","volume":"22","author":"MA Kotterman","year":"2015","unstructured":"Kotterman MA, Yin L, Strazzeri JM, Flannery JG, Merigan WH, Schaffer DV. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Gene Ther. 2015;22:116\u201326.","journal-title":"Gene Ther"},{"key":"6392_CR142","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/mt.2009.181","volume":"17","author":"D Dalkara","year":"2009","unstructured":"Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, Flannery JG. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009;17:2096\u2013102.","journal-title":"Mol Ther"},{"key":"6392_CR143","doi-asserted-by":"publisher","first-page":"189ra176","DOI":"10.1126\/scitranslmed.3005708","volume":"5","author":"D Dalkara","year":"2013","unstructured":"Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5:189ra176.","journal-title":"Sci Transl Med"},{"key":"6392_CR144","first-page":"4286","volume":"69","author":"KJ Wert","year":"2012","unstructured":"Wert KJ, Skeie JM, Davis RJ, Tsang SH, Mahajan VB. Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye. J Vis Exp. 2012;69:4286.","journal-title":"J Vis Exp"},{"key":"6392_CR145","doi-asserted-by":"crossref","unstructured":"Munis AM. Gene therapy applications of Non-Human lentiviral vectors. Viruses. 2020;12:1106.","DOI":"10.3390\/v12101106"},{"key":"6392_CR146","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1566523213666131125095046","volume":"13","author":"WS Wold","year":"2013","unstructured":"Wold WS, Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther. 2013;13:421\u201333.","journal-title":"Curr Gene Ther"},{"key":"6392_CR147","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","volume":"14","author":"Z Wu","year":"2006","unstructured":"Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther. 2006;14:316\u201327.","journal-title":"Mol Ther"},{"key":"6392_CR148","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1089\/hum.2020.070","volume":"31","author":"A Frederick","year":"2020","unstructured":"Frederick A, Sullivan J, Liu L, Adamowicz M, Lukason M, Raymer J, Luo Z, Jin X, Rao KN. O\u2019Riordan C. Engineered capsids for efficient gene delivery to the retina and cornea. Hum Gene Ther. 2020;31:756\u201374.","journal-title":"Hum Gene Ther"},{"key":"6392_CR149","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.omtm.2018.12.006","volume":"13","author":"H Song","year":"2019","unstructured":"Song H, Bush RA, Zeng Y, Qian H, Wu Z, Sieving PA. Trans-ocular electric current in vivo enhances AAV-Mediated retinal gene transduction after intravitreal vector administration. Mol Ther Methods Clin Dev. 2019;13:77\u201385.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"6392_CR150","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jgm.1126","volume":"10","author":"C Lebherz","year":"2008","unstructured":"Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med. 2008;10:375\u201382.","journal-title":"J Gene Med"},{"key":"6392_CR151","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"6392_CR152","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/gt.2012.20","volume":"19","author":"MA Bartel","year":"2012","unstructured":"Bartel MA, Weinstein JR, Schaffer DV. Directed evolution of novel adeno-associated viruses for therapeutic gene delivery. Gene Ther. 2012;19:694\u2013700.","journal-title":"Gene Ther"},{"key":"6392_CR153","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.15252\/emmm.201404077","volume":"6","author":"T Cronin","year":"2014","unstructured":"Cronin T, Vandenberghe LH, Hantz P, Juttner J, Reimann A, Kacs\u00f3 AE, Huckfeldt RM, Busskamp V, Kohler H, Lagali PS, et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. EMBO Mol Med. 2014;6:1175\u201390.","journal-title":"EMBO Mol Med"},{"key":"6392_CR154","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/hum.2016.111","volume":"28","author":"PS Ramachandran","year":"2017","unstructured":"Ramachandran PS, Lee V, Wei Z, Song JY, Casal G, Cronin T, Willett K, Huckfeldt R, Morgan JI, Aleman TS, et al. Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the Non-Human primate retina. Hum Gene Ther. 2017;28:154\u201367.","journal-title":"Hum Gene Ther"},{"key":"6392_CR155","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1038\/s41467-024-48221-4","volume":"15","author":"S Luo","year":"2024","unstructured":"Luo S, Jiang H, Li Q, Qin Y, Yang S, Li J, Xu L, Gou Y, Zhang Y, Liu F, et al. An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species. Nat Commun. 2024;15:3780.","journal-title":"Nat Commun"},{"key":"6392_CR156","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/emmm.201302948","volume":"6","author":"I Trapani","year":"2014","unstructured":"Trapani I, Colella P, Sommella A, Iodice C, Cesi G, de Simone S, Marrocco E, Rossi S, Giunti M, Palfi A, et al. Effective delivery of large genes to the retina by dual AAV vectors. EMBO Mol Med. 2014;6:194\u2013211.","journal-title":"EMBO Mol Med"},{"key":"6392_CR157","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","volume":"26","author":"A Maddalena","year":"2018","unstructured":"Maddalena A, Tornabene P, Tiberi P, Minopoli R, Manfredi A, Mutarelli M, Rossi S, Simonelli F, Naggert JK, Cacchiarelli D, Auricchio A. Triple vectors expand AAV transfer capacity in the retina. Mol Ther. 2018;26:524\u201341.","journal-title":"Mol Ther"},{"key":"6392_CR158","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hgtb.2013.212","volume":"25","author":"FM Dyka","year":"2014","unstructured":"Dyka FM, Boye SL, Chiodo VA, Hauswirth WW, Boye SE. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A. Hum Gene Ther Methods. 2014;25:166\u201377.","journal-title":"Hum Gene Ther Methods"},{"key":"6392_CR159","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","volume":"24","author":"I Trapani","year":"2015","unstructured":"Trapani I, Toriello E, de Simone S, Colella P, Iodice C, Polishchuk EV, Sommella A, Colecchi L, Rossi S, Simonelli F, et al. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease. Hum Mol Genet. 2015;24:6811\u201325.","journal-title":"Hum Mol Genet"},{"key":"6392_CR160","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","volume":"6","author":"JR Davis","year":"2022","unstructured":"Davis JR, Wang X, Witte IP, Huang TP, Levy JM, Raguram A, Banskota S, Seidah NG, Musunuru K, Liu DR. Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nat Biomed Eng. 2022;6:1272\u201383.","journal-title":"Nat Biomed Eng"},{"key":"6392_CR161","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/genbio.2022.0015","volume":"1","author":"H Zhang","year":"2022","unstructured":"Zhang H, Bamidele N, Liu P, Ojelabi O, Gao XD, Rodriguez T, Cheng H, Kelly K, Watts JK, Xie J, et al. Adenine base editing in vivo with a single Adeno-Associated virus vector. GEN Biotechnol. 2022;1:285\u201399.","journal-title":"GEN Biotechnol"},{"key":"6392_CR162","doi-asserted-by":"publisher","first-page":"88ra54","DOI":"10.1126\/scitranslmed.3002103","volume":"3","author":"LH Vandenberghe","year":"2011","unstructured":"Vandenberghe LH, Bell P, Maguire AM, Cearley CN, Xiao R, Calcedo R, Wang L, Castle MJ, Maguire AC, Grant R, et al. Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey. Sci Transl Med. 2011;3:88ra54.","journal-title":"Sci Transl Med"},{"key":"6392_CR163","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2005.07.019","volume":"108","author":"HT Le","year":"2005","unstructured":"Le HT, Yu QC, Wilson JM, Croyle MA. Utility of pegylated Recombinant adeno-associated viruses for gene transfer. J Control Release. 2005;108:161\u201377.","journal-title":"J Control Release"},{"key":"6392_CR164","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/molecules22071155","volume":"22","author":"T Yao","year":"2017","unstructured":"Yao T, Zhou X, Zhang C, Yu X, Tian Z, Zhang L, Zhou D. Site-specific pegylated Adeno-associated viruses with increased serum stability and reduced immunogenicity. Molecules. 2017;22:1155.","journal-title":"Molecules"},{"key":"6392_CR165","doi-asserted-by":"publisher","first-page":"194ra192","DOI":"10.1126\/scitranslmed.3005795","volume":"5","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, Anguela XM, Pavani G, Chen Y, Davidson RJ, Hui DJ, Yazicioglu M, Elkouby L, Hinderer CJ, Faella A, et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med. 2013;5:194ra192.","journal-title":"Sci Transl Med"},{"key":"6392_CR166","first-page":"123","volume":"4","author":"R Manservigi","year":"2010","unstructured":"Manservigi R, Argnani R, Marconi P. HSV Recombinant vectors for gene therapy. Open Virol J. 2010;4:123\u201356.","journal-title":"Open Virol J"},{"key":"6392_CR167","doi-asserted-by":"publisher","first-page":"e10258","DOI":"10.1002\/btm2.10258","volume":"7","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Anselmo AC, Mitragotri S. Viral vector-based gene therapies in the clinic. Bioeng Transl Med. 2022;7:e10258.","journal-title":"Bioeng Transl Med"},{"key":"6392_CR168","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/83324","volume":"7","author":"MA Kay","year":"2001","unstructured":"Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the Art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33\u201340.","journal-title":"Nat Med"},{"key":"6392_CR169","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/156652311797415845","volume":"11","author":"S de Silva","year":"2011","unstructured":"de Silva S, Bowers WJ. Targeting the central nervous system with herpes simplex virus \/ Sleeping beauty hybrid amplicon vectors. Curr Gene Ther. 2011;11:332\u201340.","journal-title":"Curr Gene Ther"},{"key":"6392_CR170","first-page":"1448","volume":"41","author":"M Yang","year":"2021","unstructured":"Yang M, Gao Y, Li M, Cao X, Huang X. Attenuated herpes simplex virus 1 vector expressing Oncomodulin effectively allieviates mechanical optic nerve injury in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1448\u201355.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"6392_CR171","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41573-021-00017-7","volume":"20","author":"DA Kuzmin","year":"2021","unstructured":"Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, van der Loo JCM, Johnstone EC. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173\u20134.","journal-title":"Nat Rev Drug Discov"},{"key":"6392_CR172","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403\u201316.","journal-title":"N Engl J Med"},{"key":"6392_CR173","doi-asserted-by":"publisher","first-page":"e0241006","DOI":"10.1371\/journal.pone.0241006","volume":"15","author":"RC Ryals","year":"2020","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of pegylation on LNP based mRNA delivery to the eye. PLoS ONE. 2020;15:e0241006.","journal-title":"PLoS ONE"},{"key":"6392_CR174","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C6CS00636A","volume":"46","author":"S Behzadi","year":"2017","unstructured":"Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017;46:4218\u201344.","journal-title":"Chem Soc Rev"},{"key":"6392_CR175","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1056\/NEJMc2036242","volume":"384","author":"DM Skowronski","year":"2021","unstructured":"Skowronski DM, De Serres G. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2021;384:1576\u20137.","journal-title":"N Engl J Med"},{"key":"6392_CR176","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R. The current landscape of nucleic acid therapeutics. Nat Nanotechnol. 2021;16:630\u201343.","journal-title":"Nat Nanotechnol"},{"key":"6392_CR177","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, Lynn A, Bulychev A, McFadyen I, Chan J, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained Pharmacology and safety in Non-human primates. Mol Ther. 2018;26:1509\u201319.","journal-title":"Mol Ther"},{"key":"6392_CR178","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","volume":"14","author":"M Gautam","year":"2023","unstructured":"Gautam M, Jozic A, Su GL-N, Herrera-Barrera M, Curtis A, Arrizabalaga S, Tschetter W, Ryals RC, Sahay G. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat Commun. 2023;14:6468.","journal-title":"Nat Commun"},{"key":"6392_CR179","doi-asserted-by":"publisher","first-page":"eadd4623","DOI":"10.1126\/sciadv.add4623","volume":"9","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera M, Ryals RC, Gautam M, Jozic A, Landry M, Korzun T, Gupta M, Acosta C, Stoddard J, Reynaga R. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci Adv. 2023;9:eadd4623.","journal-title":"Sci Adv"},{"key":"6392_CR180","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.13.7.7","volume":"13","author":"CZ Chambers","year":"2024","unstructured":"Chambers CZ, Soo GL, Engel AL, Glass IA, Frassetto A, Martini PGV, Cherry TJ. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. Transl Vis Sci Technol. 2024;13:7.","journal-title":"Transl Vis Sci Technol"},{"key":"6392_CR181","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.exer.2024.109899","volume":"243","author":"M Li","year":"2024","unstructured":"Li M, Liu Z, Wang D, Ye J, Shi Z, Pan C, Zhang Q, Ju R, Zheng Y, Liu Y. Intraocular mRNA delivery with endogenous MmPEG10-based virus-like particles. Exp Eye Res. 2024;243:109899.","journal-title":"Exp Eye Res"},{"key":"6392_CR182","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell. 2022;185:2806\u201327.","journal-title":"Cell"},{"key":"6392_CR183","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185:250\u201365.","journal-title":"Cell"},{"key":"6392_CR184","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massourid\u00e8s E, Sohier TJM, Corbin A, et al. Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun. 2019;10:45.","journal-title":"Nat Commun"},{"key":"6392_CR185","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An M, Raguram A, Du SW, Banskota S, Davis JR, Newby GA, Chen PZ, Palczewski K, Liu DR. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat Biotechnol. 2024;42:1526\u201337.","journal-title":"Nat Biotechnol"},{"key":"6392_CR186","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.tibtech.2023.04.002","volume":"41","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Dalby PA. Challenges in scaling up AAV-based gene therapy manufacturing. Trends Biotechnol. 2023;41:1268\u201381.","journal-title":"Trends Biotechnol"},{"key":"6392_CR187","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, Adir O, Liang H, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2:24.","journal-title":"Nat Rev Methods Primers"},{"key":"6392_CR188","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","volume":"303","author":"S Patel","year":"2019","unstructured":"Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91\u2013100.","journal-title":"J Control Release"},{"key":"6392_CR189","doi-asserted-by":"publisher","first-page":"e62097","DOI":"10.1371\/journal.pone.0062097","volume":"8","author":"CN Kay","year":"2013","unstructured":"Kay CN, Ryals RC, Aslanidi GV, Min SH, Ruan Q, Sun J, Dyka FM, Kasuga D, Ayala AE, Van Vliet K, et al. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors. PLoS ONE. 2013;8:e62097.","journal-title":"PLoS ONE"},{"key":"6392_CR190","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/mtm.2013.5","volume":"1","author":"CN de Leeuw","year":"2014","unstructured":"de Leeuw CN, Dyka FM, Boye SL, Laprise S, Zhou M, Chou AY, Borretta L, McInerny SC, Banks KG, Portales-Casamar E, et al. Targeted CNS delivery using human minipromoters and demonstrated compatibility with Adeno-Associated viral vectors. Mol Ther Methods Clin Dev. 2014;1:5.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"6392_CR191","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1152\/jn.00608.2007","volume":"98","author":"RG Gregg","year":"2007","unstructured":"Gregg RG, Kamermans M, Klooster J, Lukasiewicz PD, Peachey NS, Vessey KA, McCall MA. Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete X-linked congenital stationary night blindness. J Neurophysiol. 2007;98:3023\u201333.","journal-title":"J Neurophysiol"},{"key":"6392_CR192","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1093\/hmg\/ddv341","volume":"24","author":"ML Scalabrino","year":"2015","unstructured":"Scalabrino ML, Boye SL, Fransen KM, Noel JM, Dyka FM, Min SH, Ruan Q, De Leeuw CN, Simpson EM, Gregg RG, et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet. 2015;24:6229\u201339.","journal-title":"Hum Mol Genet"},{"key":"6392_CR193","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.celrep.2019.05.056","volume":"27","author":"N Hasan","year":"2019","unstructured":"Hasan N, Pangeni G, Cobb CA, Ray TA, Nettesheim ER, Ertel KJ, Lipinski DM, McCall MA, Gregg RG. Presynaptic expression of LRIT3 transsynaptically organizes the postsynaptic glutamate signaling complex containing TRPM1. Cell Rep. 2019;27:3107\u2013316.","journal-title":"Cell Rep"},{"key":"6392_CR194","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1128\/JVI.01327-07","volume":"81","author":"M Allocca","year":"2007","unstructured":"Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, Petrillo M, Vandenberghe LH, Wilson JM, Marigo V, Surace EM, Auricchio A. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol. 2007;81:11372\u201380.","journal-title":"J Virol"},{"key":"6392_CR195","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/bies.200900198","volume":"32","author":"CW Morgans","year":"2010","unstructured":"Morgans CW, Brown RL, Duvoisin RM. TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells. BioEssays. 2010;32:609\u201314.","journal-title":"BioEssays"},{"key":"6392_CR196","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/mt.2014.154","volume":"23","author":"E Mac\u00e9","year":"2015","unstructured":"Mac\u00e9 E, Caplette R, Marre O, Sengupta A, Chaffiol A, Barbe P, Desrosiers M, Bamberg E, Sahel JA, Picaud S, et al. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice. Mol Ther. 2015;23:7\u201316.","journal-title":"Mol Ther"},{"key":"6392_CR197","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.62.3.24","volume":"62","author":"J Varin","year":"2021","unstructured":"Varin J, Bouzidi N, Dias MMS, Pugliese T, Michiels C, Robert C, Desrosiers M, Sahel JA, Audo I, Dalkara D, Zeitz C. Restoration of mGluR6 localization following AAV-Mediated delivery in a mouse model of congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2021;62:24.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6392_CR198","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1167\/iovs.07-0257","volume":"48","author":"SC Khani","year":"2007","unstructured":"Khani SC, Pawlyk BS, Bulgakov OV, Kasperek E, Young JE, Adamian M, Sun X, Smith AJ, Ali RR, Li T. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest Ophthalmol Vis Sci. 2007;48:3954\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6392_CR199","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtm.2021.05.008","volume":"22","author":"J Varin","year":"2021","unstructured":"Varin J, Bouzidi N, Gauvain G, Joffrois C, Desrosiers M, Robert C, De Sousa Dias MM, Neuill\u00e9 M, Michiels C, Nassisi M, et al. Substantial restoration of night vision in adult mice with congenital stationary night blindness. Mol Ther Methods Clin Dev. 2021;22:15\u201325.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"6392_CR200","doi-asserted-by":"publisher","first-page":"e0137072","DOI":"10.1371\/journal.pone.0137072","volume":"10","author":"M Kondo","year":"2015","unstructured":"Kondo M, Das G, Imai R, Santana E, Nakashita T, Imawaka M, Ueda K, Ohtsuka H, Sakai K, Aihara T, et al. A naturally occurring canine model of autosomal recessive congenital stationary night blindness. PLoS ONE. 2015;10:e0137072.","journal-title":"PLoS ONE"},{"key":"6392_CR201","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/gt.2016.42","volume":"23","author":"Q Lu","year":"2016","unstructured":"Lu Q, Ganjawala TH, Ivanova E, Cheng JG, Troilo D, Pan ZH. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther. 2016;23:680\u20139.","journal-title":"Gene Ther"},{"key":"6392_CR202","doi-asserted-by":"publisher","first-page":"e2117038119","DOI":"10.1073\/pnas.2117038119","volume":"119","author":"K Miyadera","year":"2022","unstructured":"Miyadera K, Santana E, Roszak K, Iffrig S, Visel M, Iwabe S, Boyd RF, Bartoe JT, Sato Y, Gray A, et al. Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness. Proc Natl Acad Sci U S A. 2022;119:e2117038119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6392_CR203","doi-asserted-by":"publisher","first-page":"108260","DOI":"10.1016\/j.visres.2023.108260","volume":"209","author":"K Takahashi","year":"2023","unstructured":"Takahashi K, Kwok JC, Sato Y, Aguirre GD, Miyadera K. Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness. Vis Res. 2023;209:108260.","journal-title":"Vis Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06392-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06392-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T13:06:32Z","timestamp":1743858392000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06392-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6392"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06392-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Part of our work was supported by the grant from Hangzhou Bipolar Biotechnology Co., Ltd. Qingyang Ye from Hangzhou Bipolar Biotechnology Co., Ltd. has a role in the preparation of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}